Literature DB >> 6477259

Suitability of near-total laryngopharyngectomy in piriform carcinoma.

P S Dumich, B W Pearson, L H Weiland.   

Abstract

The surgical specimens from total laryngectomy and partial pharyngectomy in 20 consecutive cases of piriform sinus carcinoma were studied by whole-organ serial sectioning in the horizontal plane. There had been gross clinical involvement or fixation of the vocal cord in 19 of these cases. Histopathologic evidence of cartilage invasion or piriform apex involvement was found in 17 specimens. In 13 cases, it appeared, retrospectively, that the cancer could have been adequately encompassed without resecting the entire contralateral side of the larynx. When this element is spared, a sphincteric speaking shunt can be made. Careful preoperative assessment would have correctly predicted the suitability or danger of this approach in 18 of the 20 cases; the two indeterminate cases would have required intraoperative quick section. These findings have meaningful implications regarding the scope of conservation surgery in piriform carcinoma.

Entities:  

Mesh:

Year:  1984        PMID: 6477259     DOI: 10.1001/archotol.1984.00800360036008

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  3 in total

1.  Functional outcomes of patients with advanced pyriform sinus cancer treated with extended near-total laryngopharyngectomy and free fasciocutaneous flap reconstruction.

Authors:  Pei-Yin Wu; Yur-Ren Kuo; Seng-Feng Jeng; Cheng-Ming Hsu; Chih-Ying Su
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06-26       Impact factor: 2.503

2.  Aspiration and speech shunt stenosis in near-total laryngectomy patients.

Authors:  C Y Su
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

3.  Functional utility and oncologic safety of near-total laryngectomy with tracheopharyngeal speech shunt in a Third World oncologic center.

Authors:  A M Shenoy; P K Plinkert; N Nanjundappa; S Premalata; G R Arunodhay
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.